Form 4 for BCAX Bicara Therapeutics Inc.
Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-15 · accession 0001628280-26-002656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | 2026-01-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale | $18.02 | -149 | 214.0K | -0.1% | -$2,685 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-15 | S | D | 149 | $18.02 | 213,992 | D | — | — |